Dienogest Contraindications
Dienogest in combination with estrogen (as combined hormonal contraceptive) shares the same contraindications as other ethinyl estradiol-containing pills, including uncontrolled hypertension (≥160/100 mmHg), personal history of venous thromboembolism or arterial events, smoking over age 35, and documented thrombophilia. 1
Absolute Contraindications for Estrogen-Dienogest Combinations
When dienogest is combined with estrogen (estradiol valerate or 17β-estradiol), the following are formal contraindications based on cardiovascular risk:
Cardiovascular Conditions
- Uncontrolled hypertension (blood pressure ≥160/100 mmHg) 1
- Personal history of arterial events (coronary heart disease, myocardial infarction, or stroke) - non-hormonal methods preferred 1
- Personal history of venous thromboembolism 1
- Documented biological thrombophilia (even without clinical events) 1
Age and Smoking
- Smoking over age 35 years, especially if consuming >15 cigarettes daily 1
- The combination of estrogen-progestin contraception and smoking creates exponentially rising risk of stroke and MI with age 1
Other High-Risk Conditions
- Complicated diabetes with nephropathy, advanced retinopathy (edematous, ischemic, or proliferative), cardiovascular disease, or neuropathy 1
- Migraine with aura or family history of premature cardiovascular events (before age 50) 1
Relative Contraindications
- Controlled hypertension (blood pressure <160/100 mmHg): Contraindication is relative in women under 35 years on effective treatment without complications or other cardiovascular risk factors 1
- Family history of venous thromboembolism in first-degree relative before age 60 1
Important Clinical Context
The 2012 French Society of Endocrinology guidelines specifically note that newer estrogen-progestin combinations not using ethinyl estradiol (including estradiol valerate with dienogest) have very limited data and are subject to the same contraindications as ethinyl estradiol-containing pills until proven otherwise 1. This is a critical point - despite theoretical advantages of natural estrogens, safety data remain insufficient to modify contraindications.
Dienogest-Only Formulations
Progestin-only dienogest (2 mg daily for endometriosis treatment) has NO absolute contraindications related to cardiovascular risk and can be used in women with:
- Hypertension (controlled or uncontrolled) 1
- History of cardiovascular disease (after multidisciplinary consultation) 1
- Any smoking status at any age 1
- Thrombophilia or history of venous thromboembolism 1
Common Pitfalls to Avoid
- Don't confuse formulations: Dienogest combined with estrogen has extensive contraindications; dienogest alone does not
- Blood pressure measurement is mandatory before prescribing any estrogen-containing contraceptive, even in women without personal or family history of hypertension 1
- Don't assume natural estrogens are safer: Until Phase IV data demonstrate otherwise, estradiol-dienogest combinations carry the same contraindications as ethinyl estradiol products 1
- Age 35 is the critical threshold for smoking-related contraindications with combined hormonal contraceptives 1
The evidence consistently shows that when cardiovascular contraindications exist for combined hormonal contraceptives, progestin-only methods (including dienogest monotherapy) represent the hormonal alternative of choice 1.